Patient Education for Prostate Cancer

Phase-Based Progress Estimates
Prostate CancerPatient Education - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial will help to assess how an educational intervention on orchiectomy affects the number of patients willing to have the surgery.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: 1 year

1 year
Change in body image perception using the Hopwood BIS questionnaire in patients undergoing versus not undergoing orchiectomy.
Change in sexuality measured using the PROMIS v2.0 questionnaire in patients undergoing versus not undergoing orchiectomy.
Comparison of costs of medical versus surgical castration
Correlation of orchiectomy acceptance with race, socioeconomic status, level of education, and marital status.
Number of patients that agree to participate in an educational session on surgical orchiectomy
Number of patients that undergo orchiectomy after receiving study education intervention
Patient satisfaction with decision to under undergo orchiectomy as reported using the Regret Decision Scale.

Trial Safety

Trial Design

2 Treatment Groups

No Intervention
1 of 2
Educational Intervention
1 of 2

Active Control

Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Patient Education · No Placebo Group · N/A

Educational Intervention
Experimental Group · 1 Intervention: Patient Education · Intervention Types: Behavioral
No InterventionNoIntervention Group · 1 Intervention: No Intervention · Intervention Types:
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Education

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

University of ChicagoLead Sponsor
927 Previous Clinical Trials
753,912 Total Patients Enrolled
17 Trials studying Prostate Cancer
7,914 Patients Enrolled for Prostate Cancer
Walter Stadler, MDStudy ChairUniversity of Chicago
4 Previous Clinical Trials
108 Total Patients Enrolled
2 Trials studying Prostate Cancer
18 Patients Enrolled for Prostate Cancer

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a diagnosis of metastatic prostatic adenocarcinoma.
You are receiving LHRH agonist or LHRH antagonist therapy continuously for at least 1 year with anticipated lifelong therapy.